Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer

Background: Whole pelvic radiotherapy (WPRT) with stereotactic body radiotherapy (SBRT) boost has been shown to be effective in patients with high-risk prostate cancer (PC). However, no study has directly compared the efficacy of WPRT with SBRT boost with that of conventionally fractionated radiothe...

Full description

Bibliographic Details
Main Authors: Shih-Chang Wang, Wei-Chen Ting, Yun-Ching Chang, Ching-Chieh Yang, Li-Ching Lin, Hsiu-Wen Ho, Shou-Sheng Chu, Yu-Wei Lin
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
SBRT
conventionally fractionated
high risk
radiotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00814/full

Similar Items

Similar Items